[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP3866682A1 - Procédés et systèmes de prédiction améliorée de réactivité à un fluide - Google Patents

Procédés et systèmes de prédiction améliorée de réactivité à un fluide

Info

Publication number
EP3866682A1
EP3866682A1 EP19795749.1A EP19795749A EP3866682A1 EP 3866682 A1 EP3866682 A1 EP 3866682A1 EP 19795749 A EP19795749 A EP 19795749A EP 3866682 A1 EP3866682 A1 EP 3866682A1
Authority
EP
European Patent Office
Prior art keywords
fluid responsiveness
fluid
algorithm
features
machine learning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19795749.1A
Other languages
German (de)
English (en)
Inventor
Cvetko Nikolic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cn Medical Research LLC
Original Assignee
Cn Medical Research LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/160,778 external-priority patent/US11445975B2/en
Application filed by Cn Medical Research LLC filed Critical Cn Medical Research LLC
Publication of EP3866682A1 publication Critical patent/EP3866682A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A61B5/7267—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A61B5/029—Measuring blood output from the heart, e.g. minute volume
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Definitions

  • Figure l is a flow chart of a method of predicting fluid responsiveness of a patient using an ECG signal, according to an exemplary embodiment of the present disclosure.
  • Figure 2 illustrates a typical ECG signal over a time interval.
  • Fluid administration in a hemodynamically unstable patient constitutes a major challenge when it comes to measuring hemodynamic parameters in real time.
  • Accurate clinical assessment of hypovolemia (a state of decreased blood volume) is difficult, as is the decision to undertake fluid resuscitation as the initial treatment strategy.
  • predicting whether a hemodynamically unstable patient will positively respond to fluid therapy with an increase in stroke volume and cardiac output is very difficult.
  • an insufficient supply of fluid or blood volume can cause a suboptimal (i.e., reduced) cardiac output, which will in turn lead to hypoperfusion, insufficient tissue perfusion, and eventually, organ failure and/or dysfunction.
  • Stroke volume is the amount of blood ejected by the left ventricle of the heart in one contraction.
  • the left ventricle of the heart fills with blood until contraction during diastole (also known as the end diastolic volume, or EDV).
  • EDV end diastolic volume
  • Stroke volume is then calculated as the difference of ESV from EDV.
  • Stroke volume is then divided by EDV to determine the ejection fraction, or EF. Typical ranges of EF in healthy subjects are between 55- 70%. Stroke volume is also affected by preload and afterload. Preload is the load, or stretch, put on the ventricle by the amount of entering blood volume. As preload increases, it increases the strength of the contraction, thus increasing the stroke volume. The afterload is the resistance the ventricle must pump against to eject the stroke volume.
  • a number of methods and techniques have been developed to predict whether and how much fluid should be administered or supplied to a patient in order to maintain optimal heart operation.
  • a method that has been demonstrated to be a useful predictor of fluid responsiveness is the use of Stroke Volume Variations (“SVV”), which are variations observed in the left ventricular stroke volume that result from the interaction of the cardiovascular system and the lungs under mechanical ventilation. SVVs are caused by the cyclic increases and decreases in the intrathoracic pressure due to mechanical ventilation, which lead to variations in the cardiac preload and afterload.
  • SVVs Stroke Volume Variations
  • Another method that has been demonstrated to be a useful predictor of fluid responsiveness is the use of Pulse Pressure Variations (PPV), which are respiratory variations in arterial blood pressure.
  • PSV Pulse Pressure Variations
  • both of these methods have several disadvantages, including that they require at least some level of invasiveness (e.g. arterial line to assess blood pressure) - a drawback because the general trend in this field has been towards less invasiveness, i.e., providing interventions and monitoring to patients correlating to the sensitivity of their state.
  • patients who undergo fluid increases for example, ICU patients
  • ICU patients are typically in a sensitive state, and so should receive treatment that is less invasive (and yet optimally invasive for their sensitive state) compared to a relatively healthier patient.
  • an increased intrathoracic pressure like in the case of mechanical ventilation (for example, during anesthesia or in the ICU) can obstruct the backflow of blood to the heart (for a couple of heartbeats). This effect may be even more pronounced when a higher pressure is applied to a patient with poor blood circulation (potentially causing demasking / hypovolemia).
  • Embodiments of the present disclosure predict fluid responsiveness using the value of an electrocardiogram (ECG or EKG) signal alone and perform this function at higher ECG sampling rates.
  • ECG electrocardiogram
  • the present disclosure is completely non-invasive and does not disturb the patient in any way because its function derives from the standard functional analysis of an ECG signal.
  • ECG is a graphical representation of the electric potentials generated by the heart. It is a non-invasive and continuous monitoring method providing information from which the heart rate, underlying rhythm, activity of the atria, and the ventricles can be read in the form of an electrical signal. Such electrical signals are recorded via ECG leads placed on the surface of a body. The ECG has been exclusively used until this point as a monitoring process to monitor heart frequency and arrhythmias in anesthesiology and intensive care medicine.
  • An exemplary embodiment of the present disclosure predicts fluid responsiveness by using continuous, higher resolution ECGs (e.g., 250 Hz to 1000 Hz) to detect changes in fluid responsiveness parameters. Unlike standard ECGs at 50 Hz, a higher resolution ECG can detect very low amplitude signals in the ventricles (called“Late Potentials”) of patients with abnormal heart conditions.
  • ECGs e.g. 250 Hz to 1000 Hz
  • a higher resolution ECG can detect very low amplitude signals in the ventricles (called“Late Potentials”) of patients with abnormal heart conditions.
  • Embodiments of the present disclosure are also not based on a single parameter, but on an algorithm based on changes in an ECG signal caused by the influence of multiple physiologic variables (heart rate, breathing, vascular tone, etc.) on each other - thus providing the necessary accuracy not possible from analyzing a single parameter.
  • the present disclosure provides systems and methods for predicting fluid
  • the disclosed embodiments present a method for predicting fluid responsiveness by using continuous, higher resolution ECGs (ranging from 250 Hz to preferably 1000 Hz) to detect and process changes in fluid responsiveness parameters based on the ECG signals and generate a fluid responsiveness prediction based on those changes.
  • fluid responsiveness may be predicted using non-continuous or partially continuous higher resolution ECGs.
  • At least two sensors may be provided to obtain an ECG signal non-invasively.
  • the ECG signal may be passed from the sensors to a computer system by various methods, including via an electronic output file.
  • a processor within the computer system may be configured to detect and process changes in the ECG signal fluid responsiveness parameters (i.e. direct alterations of the ECG curves). Once these changes in the ECG signal are processed, the processor may execute a mathematical algorithm stored within a memory of the computer system to analyze and quantify the changes in the ECG signal and generate a fluid responsiveness prediction.
  • a display device may also be provided to display the results of the fluid responsiveness prediction.
  • a method includes obtaining the ECG signal non-invasively using a sensor.
  • the method includes processing changes in the ECG signal fluid responsiveness parameters (i.e. direct alterations of the ECG curves) using a computer system.
  • the method includes quantifying these changes in fluid responsiveness parameters and generating a fluid responsiveness prediction of a patient using a mathematical algorithm embodied within the computer system.
  • the method includes displaying the results of this fluid responsiveness prediction to a physician or other health care provider using a display device.
  • the method may also include a physician or other health care provider using his or her medical expertise and evaluating the results of this fluid responsiveness prediction and determining the next appropriate medical course of action for the patient.
  • This next medical course of action may include, but is not limited to, administering fluid or medication to the patient, performing other medically appropriate steps as necessary based on the results of the fluid responsiveness prediction, or do nothing at all, if medically appropriate.
  • Figure 1 illustrates of a method of predicting fluid responsiveness of a patient using an ECG signal to maintain optimal cardiac output of the patient, according to an exemplary embodiment of the present disclosure.
  • the first step may include obtaining an ECG signal from a patient non-invasively 101.
  • the second step may include processing changes in the ECG signal 102.
  • the third step may include generating a fluid responsiveness prediction 103.
  • the fourth step may include displaying the fluid responsiveness prediction 104 to a physician or other health care provider.
  • the optional fifth step may include administrating fluid or medication based on the results of the fluid responsiveness prediction 105.
  • ECG Electromyogram
  • EEG Electroencephalogram
  • Figure 2 illustrates a typical ECG signal 200 over a time interval.
  • Electrocardiography represents a transthoracic (across the thorax or chest) measurement of electrical activity of the heart over a period of time, as detected by electrodes attached to the outer surface of the skin and recorded by a device external to the body.
  • the recording produced by the noninvasive procedure is termed EKG or ECG.
  • An ECG is used to measure the rate and regularity of heartbeats, as well as the size and position of the chambers, the presence of any damage to the heart, and the effects of drugs or devices used to regulate the heart, such as a pacemaker.
  • an ECG signal 200 is shown.
  • the ECG signal 200 includes a P wave 202, a QRS complex 204, a T wave 206, and a El wave 208.
  • the P wave 202 indicates atrial depolarization, or contraction of the atrium.
  • the QRS complex 204 indicates ventricular depolarization, or contraction of the ventricles.
  • the T wave 206 indicates ventricular
  • the El wave 208 typically follows the T wave 206 and may not always be seen. El wave 208 may indicate repolarization of the papillary muscles or Purkinje fibers.
  • the size of the El wave 208 is inversely proportional to the heart rate; as the El wave 208 grows bigger, the heart rate slows down.
  • the term non-invasively indicates that no artificial methods are used during the recording of the ECG signal to create an increased intrathoracic pressure.
  • Artificial methods may include any measurements that may, for example, puncture the surface of a patient’s skin to obtain an ECG signal. Artificial methods do not include, for example, mechanical ventilation or leg raising of a patient that may be performed to improve the quality of the measurements being obtained.
  • the ECG signal may be obtained from at least two sensors coupled to a patient.
  • a sensor may be a device capable of generating continuous, high-resolution ECG data (e.g., 250 Hz to lOOOHz). Examples of such devices include commercially available ECG setups from GE Healthcare® Inc.
  • the ECG signal may be passed from the sensors to a storage device, whereby the ECG signal may be obtained from the storage device.
  • a storage device may be an apparatus capable of providing continuous, high-resolution ECG data (e.g.,
  • Embodiments of the storage device include a flash memory or hard disk drive.
  • Exemplary embodiments of the present disclosure may use continuous, high-resolution ECGs (ranging from at least 250 Hz to preferably 1000 Hz) to facilitate the fluid responsiveness prediction.
  • ECGs ranging from at least 250 Hz to preferably 1000 Hz
  • the disclosed embodiments refer to a sensor and storage device, the ECG signal may be acquired from other known types of ECG acquisition hardware.
  • the ECG signal may be passed from the sensors or the storage device to a computer system. Passing the ECG signal to the computer system may be done in various ways, including via an electronic output file (and/or related ECG acquisition hardware).
  • sensors may be configured to communicate with the computer system through wireless channels. For example, sensors may communicate using Bluetooth, near-field, WiFi, or other wireless communication protocols. Sensors may be lightweight, compact, and portable.
  • sensors may be configured to be worn by a patient (or test subject) and to measure ECG signals of the person wearing the sensor. Wearable sensors may be configured to be worn on a person’s wrist, arm, leg, strapped around the person’s chest, etc. In further embodiments, may other types of sensors may be used to measure ECG signals and to provide such ECG signals to a computer system using available wired or wireless technology.
  • the computer system may be a device, apparatus, and system capable of processing continuous, high-resolution ECG data (e.g., 250 Hz to lOOOHz).
  • Embodiments of the computer system include commercially available desktop computer systems such as a PowerMac®.
  • the computer system may include a general-purpose control unit, such as a processor or microprocessor connected to an internal bus, data acquisition, data storage, and/or input/output devices including a display device and printer.
  • the processor or microprocessor may be configured to execute software, which may include an operating system and one or more applications, as part of performing the functions described herein.
  • a read-only memory (ROM), a random access memory (RAM), user inputs, and a display device may also be operatively connected to the bus.
  • the RAM and the ROM are illustrated by way of example, and not limitation. Any suitable computer-readable media may be used in the system for data storage. Computer- readable media are configured to store information that may be interpreted by the
  • the information may be data or may take the form of computer-executable instructions, such as software applications, that cause the microprocessor to perform certain functions and/or computer-implemented methods.
  • the computer-readable media may include computer storage media and communication media.
  • the computer storage media may include volatile and non-volatile media, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable instructions, data structures, program modules or other data.
  • the computer storage media may include, but are not limited to, RAM, ROM, EPROM, EEPROM, flash memory or other solid state memory technology, CD-ROM, DVD, or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which may be used to store desired information and that may be accessed by components of the system.
  • a processor within the computer system may detect, analyze, and process changes in the fluid responsiveness parameters (i.e., direct alterations of the ECG curves) to create a prognostic index.
  • the processor may be configured to detect and process changes in at least one of the length, amplitude, slope, area, depth, and height of at least one of the P, Q, R, S, T, and El complex (see Figure 2) of the ECG signal caused by the influence of various physiological variables on each other to create the prognostic index.
  • This prognostic index may be based on processed changes in the ECG signal fluid responsiveness parameters caused by the influence of at least two or more physiological variables on each other such as heart rate, breathing, and/or vascular tone.
  • the changes in the ECG signal may be detected in volume depleted patients comparing ECG periods during the end of inflation of a ventilator hub and during the end of the exhalation period (i.e., during periods of differing intrathoracic pressures).
  • An alternative embodiment of the present disclosure may involve the use of methods and systems of the present disclosure in spontaneous breathing patients.
  • the prognostic index (and subsequently generated fluid responsiveness prediction) may be based on several relative changes in at least one of the P, Q, R, S, T, and El complexes of the ECG curve, including, but not limited to, at least one of the absolute length of the P wave / 10-25 %, the absolute amplitude of the P wave / 10-30 %, the slope of the P wave / 5-25 %, the area under the curve of the P wave / 10-30 %, the PQ segment / 15-35 %, the absolute length of the QRS complex, the slope of the decrease from isoelectric to the Q point, the slope of the increase towards the R point, the absolute depth of the Q point, the absolute height of the R point, the area under the curve of the QRS complex, the absolute length of the ST segment, the absolute length of the ST segment including the T wave, the absolute length of the ST segment including the El wave, the distance from the beginning of the P wave and the top of the P wave to the top of R, the
  • the fluid responsiveness prediction may be based on the change in vector, change of a heart’s electrical axis of the respective ECG leads. All of these changes in the P, Q, R, S, and T complexes of the ECG curve may be observed in fluid responsive patients in a digital overlay of ECG curves comparing a curve during end of inflation (ventilator hub) to end of exhalation. Further, all of these changes may be within a range of 10- 30 % - the more volume depleted (fluid responsive) a patient is, the higher the difference in his or her corresponding intra-thoracic pressure.
  • the prognostic index may include data derived from observations and comparisons of changes in multiple patients. Particularly, the larger the number of empirical data points present, i.e. the larger the number of patients evaluated, the more comparative data may be obtained. Further, the longer the empirical data points are recorded/collected from individual patients, the more comparative data may be obtained.
  • the prognostic index may therefore include both existing data collected based on changes in the P, Q, R, S, T, and U complexes of high-resolution ECG signals in multiple patients, and/or newly collected data based on the same changes from an individual patient.
  • the existing data may act as a baseline to which the newly collected data may be compared.
  • the prognostic index may only include newly collected data from an individual patient. In this embodiment, varying information within the newly collected data may be analyzed and compared to each other.
  • embodiments of the present method may include using a high-resolution ECG device to generate a prognosis based on comparing changes in at least one of the P, Q, R, S, T, and U complexes of high-resolution ECG signals relative to a pre-determined prognostic index based on data collected from multiple patients, or relative to each other based on data collected from an individual patient.
  • Embodiments of the present disclosure may employ various methods for detecting, analyzing, and processing the changes in at least one of the P, Q, R, S, T, and U complexes of multiple ECG signals.
  • this analysis may be based on a
  • the Simpson's rule is a method for numerical integration, the numerical approximation of definite integrals. If the function being integrated is relatively smooth over a time interval, the Simpson’s rule may be used to obtain an adequate estimated approximation of underlying data to the exact integral. However, when trying to integrate numerical data that is not smooth over a time interval (as may be the case for the data in the prognostic index described herein), the Simpson's rule may not be as accurate.
  • the Simpson's rule may then be applied to each subinterval, with the results being summed to produce an approximation for the integral over the entire interval.
  • this modified application of the Simpson’s rule i.e., the Composite Simpson's rule
  • other suitable methods of analysis may be used to analyze the data in the prognostic index.
  • the processor may execute a mathematical algorithm stored within a memory of the computer system to analyze, quantify, and combine the prognostic index of the changes in the ECG signal and generate a fluid responsiveness prediction based on numerical data in the prognostic index.
  • the fluid responsiveness prediction may be obtained based on an analysis and comparison of existing and newly collected data in the prognostic index.
  • the fluid responsiveness prediction may be generated by analyzing and comparing data obtained from one data set (i.e. from one patient being evaluated) to an established data set in the prognostic index (i.e. from multiple patients).
  • the fluid responsiveness prediction may be generated by analyzing and comparing data obtained from one data set (i.e. from one patient being evaluated) to an established data set in the prognostic index (i.e. from multiple patients).
  • the fluid may be generated by analyzing and comparing data obtained from one data set (i.e. from one patient being evaluated) to an established data set in the prognostic index (i.e. from multiple patients).
  • the fluid
  • responsiveness prediction may be generated by analyzing and comparing changes in fluid responsiveness in an individual patient. For example, in an embodiment, data being collected from a patient may indicate certain ECG curves with relatively higher“spikes” /“peaks” than other ECG curves of the same patient or other patients based on existing data in the index. These spikes may be evaluated and characterized as numerical data via the methods of analysis described herein. A fluid responsiveness prediction comparing the newly collected and existing data may then be generated and displayed in various forms, including but not limited to as a table, listing, chart, and/or other suitable visual depictions such as a digital overlay of ECG curves.
  • the generated fluid responsiveness prediction may be displayed on a display device communicatively coupled to the computer system.
  • the display device may be a cathode ray tube display, a flat panel display, such as a liquid crystal display (LCD), a light-emitting diode (LED) display, a plasma display, or other type of monitor.
  • Embodiments of the display device include commercially available monitors, such as an Apple Thunderbolt Display. It will be understood that other suitable metrics may be displayed to indicate levels of fluid responsiveness, such as by a status bar, a visual alarm, an audible alarm, any other suitable indication, or combinations thereof.
  • the level of fluid responsiveness may also be outputted to suitable output devices, such as a computer, a computer-readable medium, a printer, or combinations thereof.
  • An exemplary embodiment of the disclosure may further include the optional fifth step whereby a physician or other health care provider may review the results of the generated fluid response prediction on the display device and make the medical determination to administer fluid to a patient 105.
  • An alternative exemplary embodiment of the disclosure may include the optional fifth step whereby the physician or other health care provider reviews the results of the generated fluid response prediction on the display device and instead makes the determination to administer medication to the patient 105. This scenario will likely arise in a case where an increased supply of fluid or blood volume may not provide any benefit to a patient with decreased heart frequency or contractility; instead, the patient may need heart muscle
  • strengthening medication such as catecholamines, adrenaline, or their derivatives.
  • An alternative exemplary embodiment of the disclosure may include the optional fifth step whereby the physician or other health care provider may review the results of the generated fluid response prediction on the display device and instead make the determination, based on his or her expertise, to follow another medically appropriate course of action for the patient 105.
  • Yet another exemplary embodiment of the disclosure may include a scenario whereby the health care provider or other authorized person may review the results of the generated fluid response prediction on the display device and come to the conclusion that the patient does not need any additional medical treatment at all 105.
  • a hemodynamically unstable patient’s fluid responsiveness may be obtained by the following method.
  • At least two sensors described herein may first be coupled to the patient and used to obtain the patient’s ECG signal (e.g., see Figure 2).
  • the ECG signal may be passed from the sensors to a computer system described herein.
  • a processor within the computer system may then detect, analyze, and process changes in at least one of the length, amplitude, slope, area, depth, and height of at least one of the P, Q, R, S, T, and EG complex of the ECG signal caused by the influence of the patient’s various physiological variables on each other to create a prognostic index described herein.
  • the patient’s ECG signal may indicate some curves with a higher“spike” / “peak” than other curves.
  • the processor may analyze and compare the area under the curve of the QRS complex of the“spiked” curve with the area under the curve of the QRS complex in another non-spiked curve. This calculation and analysis of the area under the curves of the spiked and non-spiked QRS complexes may be performed using the Composite Simpson’s rule described herein.
  • the processor may then generate a fluid responsiveness prediction based on this data.
  • the prognostic index may only include relevant newly collected data from this patient being evaluated.
  • the relevant data from the spiked curve may be processed and compared to the data from the non-spiked curve and displayed in a suitable viewable format, e.g., a comparative chart.
  • the prognostic index may include relevant newly collected data from both the patient being evaluated as well as baseline data from multiple patients for comparison to the newly collected data. A physician viewing this comparative chart may then make the medical determination to administer fluid or medication, follow an entirely different medically appropriate course of action, or not take any further action.
  • a machine learning algorithm may be used to generate a model for a relationship between fluid responsiveness and an ECG signal.
  • a machine learning algorithm may generate a classifier model.
  • a plurality of training data sets may be used to generate the model.
  • Each data set may be processed to identify a number of features of the data.
  • each ECG signal may be analyzed to determine a plurality of features.
  • a feature may correspond to a peak of an ECG signal and each peak may be characterized by a peak height, an area under the curve of the ECG signal for the portion of the signal corresponding to the peak, etc.
  • Features P, Q, R, S, T, and El may be identified as features in an ECG signal, as described in greater detail above.
  • Each feature may be considered to define a coordinate direction in a multi
  • a value associated with each peak may be taken to define a coordinate in the multi-dimensional space.
  • a peak height, an area under the curve for a given peak, etc. may be used to define a coordinate in the multi -dimensional space.
  • a given ECG signal may be represented as a single point in the multi-dimensional space. For example, suppose an ECG signal is analyzed to determine characteristic values (p, q, r, s, t, u)
  • the data may be represented by the point (p, q, r, s, t, u).
  • p may be the peak height or area under the curve for feature P
  • q may be the peak height or area under the curve for feature Q, etc.
  • a plurality of N data sets may be reduced to a corresponding plurality of N points in the multi-dimensional space.
  • the space would be a six dimensional space corresponding to the six features P, Q, R,
  • a classifier may be built as follows.
  • a set of A ECG curves may be taken as training data.
  • Each ECG curve may be analyzed to determine the set of values (p, q, r, s, t, u)
  • each of the data sets may be given one of two labels (e.g., 0 and 1) that classify each point as being in one or the other classes of data.
  • Machine learning techniques may then be used to build a model.
  • the model is represented mathematically as a hyperplane (i.e., a linear separator) or a hypersurface (i.e., a non-linear separator) in the multi-dimensional space that best separates the data into the two classes.
  • the hyperplane or hypersurface may be represented, respectively, as a linear or non-linear function in the multi-dimensional space.
  • the hyperplane or hypersurface may be used to generate predictions of the model.
  • a multi-dimensional data point e.g., a point of the form (p, q, r, s, t, u) for the example above
  • the input point may be predicted to correspond to one of the two classes that were used to define the model.
  • a new data point (i.e., a previously un-seen data point) may be characterized as belonging to one of the two classes that were used to define the model based on its location in the multi-dimensional space relative to the hyperplane or hypersurface that defines the classifier model.
  • a correlation between a patient’s ECG signal and fluid responsiveness may be determined.
  • a plurality of training data sets i.e., ECG signals
  • ECG signals may be analyzed to determine multi-dimensional coordinates (p, q, r, s, t, u).
  • each data point may be characterized as (0) fluid non-responsive, or (1) fluid responsive.
  • a model of fluid-responsiveness may then be generated from the training data.
  • a responsiveness index may be defined for each new data point corresponding to new ECG signals.
  • a patient’s ECG signal may be measured and a responsiveness index may be determined based on the model.
  • a set of training data may be divided into three or more classifications.
  • machine learning methods may be applied to define various regions in the multi-dimensional space corresponding to the three or more classification categories.
  • a model may be built to make predictions regarding new (i.e., unseen) data.
  • the various alternatives predicted by the model may correspond to three or more classifications of treatment options for a given patient based on his/her measured ECG signal.
  • a raw ECG signal (having been taken with high frequency sampling) is provided as input and a fluid responsiveness index is generated by the model as output.
  • an ECG signal may be read from a 1000 Hz ECG device.
  • Computational techniques may then be applied to determine a set of features from the input ECG signal, and to thereby characterize the signal in terms of coordinates in a multi-dimensional space.
  • a plurality of such data points is used to generate the model.
  • a fluid responsiveness index is generated by the model based on an input ECG signal.
  • the fluid responsiveness index may characterize whether a patient may benefit from administration of fluid/blood that would in turn cause the patient to have an increased cardiac output.
  • An alternative treatment may be prescribed in cases in which the fluid responsiveness index predicts that a patient would not benefit from administration of fluid/blood.
  • a patient may benefit from heart strengthening medications, such as catecholamines, adrenaline, etc. This in this example of how embodiment methods may be employed to automatically determine a diagnosis based on a measured input signal, such as a patent’s measured ECG.
  • machine learning models may be based on regression models, decision trees, neural networks, etc.
  • features may be pre-determined.
  • a model may be constructed by assuming the only features will be the P, Q, R, S, T, and U, features described above.
  • computational techniques may be used to determine characteristic values (p, q, r, s, t, u) for each of the pre-determined features, as described above.
  • machine learning techniques may be used to build the model, as described above.
  • this embodiment may be referred to as the engineering version of the method.
  • the features themselves may be identified during the training process.
  • the distinction from A (engineering version) is in the manner in which the features are determined.
  • the feature set is not pre-determined, but is determined
  • the raw signal (or some appropriately pre-processed version of it) is fed through a deep learning network, which has been trained during the training process to both calculate an optimal feature set, and then to utilize this set to determine the fluid responsiveness index.
  • a method may be defined to lie somewhere between methods A and B, above.
  • a neural network for example a recurrent neural network (RNN), that acts on the initial raw ECG signal, and converts that raw ECG signal to generate“learned” features.
  • the learned features may then be combined, for example by concatenation, into a larger object (e.g., a vector or a tensor) that includes both learned and engineered features.
  • the larger object may then be used as input to a neural network that outputs a set of classes, in the case of (multi-task) classification, or a set of real numbers, in the class of (multi-task) regression.
  • bio-signals may be used to characterize fluid responsiveness instead of, or in addition to ECG signals.
  • other features may be defined in addition to, or instead of, peak heights and areas under the curve corresponding to feature peaks. Such features may include (but are not limited to): the raw sampled high-frequency (e.g. 1000 Hz) ECG signal itself;
  • Such features may be determined by the model, rather than engineered explicitly, for example, using modem neural network approaches including (but not limited to): multi-layer perceptrons, deep convolutional neural networks, recurrent neural networks, restricted
  • Machine learning methods may include (but not limited to) k-means clustering, mixture of Gaussians, factor or principal components analysis, deep (variational) autoencoders, or deep generative models.
  • the input to the above subsidiary models may be any set of hand engineered features, including the raw ECG signal itself. These automatically obtained features may then be utilized as part of the main training process in order to determine the fluid responsiveness.
  • machine learning models may be generated based on a training process.
  • the training process may be based on a training dataset of ECG signals for which the fluid responsiveness prediction has been measured. For example, measurements may be made on human subjects or during experiments using animals. For example, ECG signals may be measured for animal test subjects including, swine, sheep, etc.
  • animal subjects may be used to determine correlations between measured ECG signals and fluid responsiveness. For example, fluid levels may be increased (e.g., through fluid loading) or decreased (e.g., through bleeding) on animal subjects (e.g., performed on swine or sheep). Data may also be gathered on human subjects undergoing anesthesia. Trends based on animal subjects may then be correlated to trends based on human subjects using Bland- Altman plotting/correlation techniques. With animal subjects, data sets may be gathered during experiments in which a certain fluid volume is changed in a
  • Such data sets may be well suited to be used as training data sets for machine learning algorithms.
  • Feature sets calculated from measured ECG signals for training data sets may be referred to as X, while measured outputs (i.e. the measured fluid responsiveness) may be referred to as Y.
  • the machine learning model determines correlations between X and Y.
  • the output Y may consist of a set of classes, in the case of (multi-task) classification, or a set of real numbers, in the class of (multi-task) regression.
  • training of a machine learning model may proceed via a supervised learning algorithm, and the model architecture may include (but is not limited to):
  • a discriminative learning algorithm such as: linear regression (possibly using kernel methods), a neural network algorithm, for example a multi-layer perceptron, deep convolutional neural network, recurrent neural network, restricted Boltzmann machine, or
  • the output may be determined via a theoretical model, that is, by a set of theoretical equations that relates the ECG signal to the blood output of the heart.
  • a correlation may be based on inclusion of other metrics such as blood pressure variations, an oxymetry curve, or other homeostatic time dependent metrics.
  • hyperparameters which may include (but are not limited to): a number of hidden layers, layer sizes, choices between recurrent, convolutional, or fully connected layers.
  • the parameters for a particular architecture may be determined using a standard optimization approach that aims to minimize a difference between a predicted output and a measured output Y utilizing an appropriate cost function, such as (but not limited to) a quadratic cost function, cross-entropy, Hellinger distance, or the Kullback-Leibler divergence.
  • a particular advantage of deep neural network algorithms is that they may bypass a need to engineer complex features such as those described above, but may work well on raw input data, or a simple transformation or course graining thereof, for example Fourier transforms with a frequency cutoff if necessary. In this regard, they are a lot more data agnostic than algorithms used before deep learning algorithms were developed. Deep learning algorithms do not require detailed knowledge of features specific to cardiology, and their performance is often superior to algorithms pre-dating the development of deep learning algorithms. In this sense, a raw ECG signal itself may be used as input, with the neural network determining the optimal features most suitable for generating the desired output (e.g., for determining the fluid responsiveness).
  • a complete ECG curve may be used as input to a model that detects hypoxia by detecting trends in changes of a distance (i.e., time interval) between S and T features of the ECG curve.
  • a distance i.e., time interval
  • Such methods may be applied to other applications of cardiac rhythmology. For example, before a pathological heart rhythm appears (e.g. extrasystole, fibrillation, etc.) there may be characteristic changes in the ECG curve.
  • the above-described neural network models may be of use in automated implantable defibrillators.
  • discrete classifier models may be used to complement/validate results obtained by other machine learning models (e.g., regression type neural network models).
  • a result of such a discrete classifier model would be a prescription of whether fluid challenge (e.g., increasing PEEP) should be administered to a patient or not.
  • a discrete classifier model may prescribe a course of action from three or more possible actions.
  • Machine learning techniques that use discrete classifier models may include (but are not limited to): logistic regression, support vector machines, or any of the above-named neural network approaches, but with a discrete output (achieved for example via a softmax layer).
  • the training data for such classifier models may be classified in terms of various categories. For example, several categories may be assigned to data from situation is which various corresponding doctor decisions were made. Such categorized data may be used as training data for classifier models.
  • training data may be obtained by identifying volume depletion via one or more simple measures such as shortly increasing PEEP, by performing a passive leg raising test, or by administering blood when a fluid responsiveness index falls below a certain value.
  • the decision to administer fluid may be made based on when a value of the fluid responsiveness index falls within a first range of values. Further the amount of fluid may be determined based on the value of the fluid responsiveness index within the first range of values. Similarly, a decision to administer medication to the human subject may be made based on when the value of the fluid responsiveness index falls within a second range of values.
  • the dose of medication may be determined based on the value of the fluid
  • Various embodiments described herein provide a tangible and non-transitory (for example, not an electric signal) machine-readable medium or media having instructions recorded thereon for a processor or computer to operate a system to perform one or more embodiments of methods described herein.
  • the medium or media may be any type of CD-ROM, DVD, floppy disk, hard disk, optical disk, flash RAM drive, or other type of computer-readable medium or a combination thereof.
  • the various embodiments and/or components also may be implemented as part of one or more computers or processors.
  • the computer or processor may include a computing device, an input device, a display unit and an interface, for example, for accessing the Internet.
  • the computer or processor may include a microprocessor.
  • the microprocessor may be connected to a
  • the computer or processor may also include a memory.
  • the memory may include Random Access Memory (RAM) and Read Only Memory (ROM).
  • RAM Random Access Memory
  • ROM Read Only Memory
  • the computer or processor may also include a storage device, which may be a hard disk drive or a removable storage drive such as a floppy disk drive, optical disk drive, and the like.
  • the storage device may also be other similar systems for loading computer programs or other instructions into the computer or processor.
  • the term computer or module may include any processor-based or microprocessor- based system including systems using microcontrollers, reduced instruction set computers (RISC), application specific integrated circuits (ASICs), logic circuits, and any other circuit or processor capable of executing the functions described herein.
  • RISC reduced instruction set computers
  • ASICs application specific integrated circuits
  • the above examples are exemplary only, and are thus not intended to limit in any way the definition and/or meaning of the term computer.
  • the computer or processor executes a set of instructions that are stored in one or more storage elements, in order to process input data.
  • the storage elements may also store data or other information as desired or needed.
  • the storage element may be in the form of an information source or a physical memory element within a processing machine.
  • the set of instructions may include various commands that instruct the computer or processor as a processing machine to perform specific operations such as the methods and processes of the various embodiments of the subject matter described herein.
  • the set of instructions may be in the form of a software program.
  • the software may be in various forms such as system software or application software. Further, the software may be in the form of a collection of separate programs or modules, a program module within a larger program or a portion of a program module.
  • the software also may include modular programming in the form of object-oriented programming.
  • the processing of input data by the processing machine may be in response to user commands, or in response to results of previous processing, or in response to a request made by another processing machine.
  • the terms software and firmware are interchangeable, and include any computer program stored in memory for execution by a computer, including RAM memory, ROM memory, EPROM memory, EEPROM memory, and non-volatile RAM (NVRAM) memory.
  • RAM memory random access memory
  • ROM memory read-only memory
  • EPROM memory erasable programmable read-only memory
  • EEPROM memory electrically erasable programmable read-only memory
  • NVRAM non-volatile RAM

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Artificial Intelligence (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Mathematical Physics (AREA)
  • Fuzzy Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

La présente invention concerne des systèmes et des procédés de prédiction de réactivité à un fluide. Des modes de réalisation comprennent des capteurs conçus pour obtenir un signal d'électrocardiogramme à haute résolution et un système informatique connecté aux capteurs qui détecte et traite des changements parmi l'un des éléments suivants: la longueur, l'amplitude, la pente, la zone, la profondeur, et la hauteur d'au moins un des complexes P, Q, R, S, T et U du signal d'électrocardiogramme provoqué par l'influence de variables physiologiques entre elles afin de créer un indice de pronostic. L'indice de pronostic des changements dans le signal d'électrocardiogramme peut ensuite être utilisé pour générer une prédiction de réactivité au fluide. La prédiction de réactivité au fluide peut ensuite être utilisée pour gérer l'administration de fluide destiné à des patients qui reçoivent une anesthésie pendant une chirurgie ou qui sont gravement malades ou sans réactivité. Des modes de réalisation de l'invention peuvent également être utilisés en tant qu'outil de diagnostic pour des athlètes pendant l'entraînement, qui sont soumis à des tests d'endurance, pour des cyclistes, etc.
EP19795749.1A 2018-10-15 2019-10-14 Procédés et systèmes de prédiction améliorée de réactivité à un fluide Pending EP3866682A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/160,778 US11445975B2 (en) 2015-07-27 2018-10-15 Methods and systems for improved prediction of fluid responsiveness
PCT/US2019/056074 WO2020081433A1 (fr) 2018-10-15 2019-10-14 Procédés et systèmes de prédiction améliorée de réactivité à un fluide

Publications (1)

Publication Number Publication Date
EP3866682A1 true EP3866682A1 (fr) 2021-08-25

Family

ID=68393105

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19795749.1A Pending EP3866682A1 (fr) 2018-10-15 2019-10-14 Procédés et systèmes de prédiction améliorée de réactivité à un fluide

Country Status (3)

Country Link
EP (1) EP3866682A1 (fr)
JP (1) JP7295962B2 (fr)
WO (1) WO2020081433A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240126485A (ko) * 2023-02-13 2024-08-21 주식회사 지오비전 공동 다층 퍼셉트론 모델을 이용한 약제 농도 모니터링 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9538933B2 (en) 2007-09-12 2017-01-10 Koninklijke Philips N.V. QT interval monitoring system with alarms and trending
US20100324827A1 (en) * 2009-06-18 2010-12-23 Nellcor Puritan Bennett Ireland Fluid Responsiveness Measure
US9245107B2 (en) 2012-12-21 2016-01-26 Paypal, Inc. Systems and methods for determining a strength of a created credential
WO2016070128A1 (fr) 2014-10-31 2016-05-06 Irhythm Technologies, Inc. Dispositif et systèmes sans fil de surveillance physiologique
US10426364B2 (en) * 2015-10-27 2019-10-01 Cardiologs Technologies Sas Automatic method to delineate or categorize an electrocardiogram
CA3007457C (fr) * 2015-12-07 2023-01-03 Medici Technologies, LLC Procedes et appareils pour l'evaluation et la gestion de l'etat hemodynamique

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MACIEJ A MAZUROWSKI ET AL: "Deep learning in radiology: an overview of the concepts and a survey of the state of the art", 9 February 2018 (2018-02-09), XP055468753, Retrieved from the Internet <URL:https://arxiv.org/pdf/1802.08717.pdf> *
See also references of WO2020081433A1 *
TIANYU ZHOU ET AL: "Combining CNN with Hand-Crafted Features for Image Classification", 2018 14TH IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING (ICSP), IEEE, 12 August 2018 (2018-08-12), pages 554 - 557, XP033524382, DOI: 10.1109/ICSP.2018.8652428 *
XIA XIAOHAN ET AL: "Video Emotion Recognition using Hand-Crafted and Deep Learning Features", 2018 FIRST ASIAN CONFERENCE ON AFFECTIVE COMPUTING AND INTELLIGENT INTERACTION (ACII ASIA), IEEE, 20 May 2018 (2018-05-20), pages 1 - 6, XP033407016, DOI: 10.1109/ACIIASIA.2018.8470326 *

Also Published As

Publication number Publication date
WO2020081433A1 (fr) 2020-04-23
JP2022508704A (ja) 2022-01-19
JP7295962B2 (ja) 2023-06-21

Similar Documents

Publication Publication Date Title
US11445975B2 (en) Methods and systems for improved prediction of fluid responsiveness
US8388542B2 (en) System for cardiac pathology detection and characterization
EP2734103B1 (fr) Moniteur de la réserve hémodynamique et contrôle de l&#39;hémodialyse
US8668649B2 (en) System for cardiac status determination
CN102551699B (zh) 非侵入性心输出量确定的系统
US9706952B2 (en) System for ventricular arrhythmia detection and characterization
US10278595B2 (en) Analysis and characterization of patient signals
US20110172545A1 (en) Active Physical Perturbations to Enhance Intelligent Medical Monitoring
EP2542148B1 (fr) Perturbations physiques actives pour améliorer la surveillance médicale intelligente
US20210128047A1 (en) Non-invasive system and method for monitoring lusitropic myocardial function in relation to inotropic myocardial function
US10869631B2 (en) Method and system for assessing fluid responsiveness using multimodal data
KR102467212B1 (ko) 웨어러블 심전도 패치를 이용한 재택 심장 재활 시스템
US11284836B2 (en) Methods and systems for improved prediction of fluid responsiveness
US20160135704A1 (en) Matrix-Based Patient Signal Analysis
US9320445B2 (en) System for cardiac condition detection responsive to blood pressure analysis
US20160287092A1 (en) Blood vessel mechanical signal analysis
JP7295962B2 (ja) 輸液反応性の改善された予測のための方法およびシステム
US9402571B2 (en) Biological tissue function analysis
US8460200B2 (en) Physiologic parameter monitoring apparatus
US10251564B2 (en) Thermal patient signal analysis
Kareem et al. Establishing the safety of a smart heart health monitoring service through validation
JP2023517567A (ja) 波形ベースの血行動態不安定性警告
US20240298903A1 (en) Blood pressure estimation
US10398321B2 (en) Thermal patient signal analysis
WO2023107508A2 (fr) Traitement de signal de pression auriculaire gauche (lap) pour calculer automatiquement un rapport a/v

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210512

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230412